查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1309965

药物释放型支架市场：药物涂层，按用途- 全球预测 2023-2030

Drug Eluting Stent Market by Drug Coating, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球药物释放型支架市场规模将达727,295万美元，年复合成长率为10.82%，大幅成长，2030年将达到1494927万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球药物释放型支架市场至关重要。透过检验业务策略和产品满意度等关键指标，它可以对供应商进行全面评估，使用户能够根据自己的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.药物释放型支架的全球市场规模及预测为何？

2.在预测期内，COVID-19对全球药物释放型支架市场的阻碍因素与影响有哪些？

3.预测期内全球药物释放型支架市场需要投资哪些产品/细分市场/应用/领域？

4.全球药物释放型支架市场的竞争策略为何？

5. 全球药物释放型支架市场的技术趋势和法律规范是什么？

6.全球药物释放型支架市场主要厂商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入全球药物释放型支架市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 老年人口增加，罹患动脉疾病的风险增加
      • 动脉粥状硬化盛行率上升
      • 糖尿病和心臟骤停等慢性病罹患率增加
    • 抑制因素
      • 与药物释放型支架相关的风险
    • 机会
      • 引入生物可吸收支架支持微创手术
      • 改善新兴国家的医疗基础设施
    • 任务
      • 产品召回问题
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章药物释放型支架市场

  • 无聚合物涂层
    • 微孔表面
    • 微结构表面
    • 奈米多孔表面
    • 开槽管状表面
  • 聚合物基涂料
    • 可生物降解聚合物
    • 不可生物降解的聚合物

第7章药物释放型支架市场：依用途

  • 冠状动脉疾病
  • 週边动脉疾病

第8章美洲药物释放型支架市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第9章亚太药物释放型支架市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲药物释放型支架市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第11章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第12章上市公司名单

第13章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-807A20B5CCDA

The Global Drug Eluting Stent Market is forecasted to grow significantly, with a projected USD 7,272.95 million in 2023 at a CAGR of 10.82% and expected to reach a staggering USD 14,949.27 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Eluting Stent Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Eluting Stent Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Coating, market is studied across Polymer Free Coatings and Polymer-Based Coatings. The Polymer Free Coatings is further studied across Micro Porous Surface, Micro Structured Surface, Nanoporous Surface, and Slotted Tubular Surface. The Polymer-Based Coatings is further studied across Biodegradable Polymers and Non-Biodegradable Polymers. The Polymer-Based Coatings is projected to witness significant market share during forecast period.

Based on Application, market is studied across Coronary Artery Disease and Peripheral Artery Disease. The Peripheral Artery Disease is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Eluting Stent Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Eluting Stent Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Eluting Stent Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Eluting Stent Market?

4. What is the competitive strategic window for opportunities in the Global Drug Eluting Stent Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Eluting Stent Market?

6. What is the market share of the leading vendors in the Global Drug Eluting Stent Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Eluting Stent Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Drug Eluting Stent Market, by Drug Coating, 2022 vs 2030
  • 4.3. Drug Eluting Stent Market, by Application, 2022 vs 2030
  • 4.4. Drug Eluting Stent Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing geriatric population along with growing high risk of developing arterial diseases
      • 5.1.1.2. Rising prevalence rate of atherosclerosis
      • 5.1.1.3. Increasing prevalence of chronic diseases, such as diabetes and cardiac arrest
    • 5.1.2. Restraints
      • 5.1.2.1. Risks associated with drug eluting stent
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of bio resorbable stents support minimally invasive surgeries
      • 5.1.3.2. Improving healthcare infrastructure in emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to product recall
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Drug Eluting Stent Market, by Drug Coating

  • 6.1. Introduction
  • 6.2. Polymer Free Coatings
    • 6.2.1. Micro Porous Surface
    • 6.2.2. Micro Structured Surface
    • 6.2.3. Nanoporous Surface
    • 6.2.4. Slotted Tubular Surface
  • 6.3. Polymer-Based Coatings
    • 6.3.1. Biodegradable Polymers
    • 6.3.2. Non-Biodegradable Polymers

7. Drug Eluting Stent Market, by Application

  • 7.1. Introduction
  • 7.2. Coronary Artery Disease
  • 7.3. Peripheral Artery Disease

8. Americas Drug Eluting Stent Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Drug Eluting Stent Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Drug Eluting Stent Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DRUG ELUTING STENT MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG ELUTING STENT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DRUG ELUTING STENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2022 VS 2030 (%)
  • FIGURE 5. DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. DRUG ELUTING STENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. DRUG ELUTING STENT MARKET DYNAMICS
  • FIGURE 8. DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. DRUG ELUTING STENT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. DRUG ELUTING STENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DRUG ELUTING STENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DRUG ELUTING STENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 5. DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DRUG ELUTING STENT MARKET SIZE, BY MICRO POROUS SURFACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DRUG ELUTING STENT MARKET SIZE, BY MICRO STRUCTURED SURFACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DRUG ELUTING STENT MARKET SIZE, BY NANOPOROUS SURFACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DRUG ELUTING STENT MARKET SIZE, BY SLOTTED TUBULAR SURFACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 12. DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DRUG ELUTING STENT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. DRUG ELUTING STENT MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. DRUG ELUTING STENT MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. DRUG ELUTING STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. DENMARK DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EGYPT DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. FINLAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FRANCE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. GERMANY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ITALY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NORWAY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. POLAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. QATAR DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SPAIN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. TURKEY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. DRUG ELUTING STENT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 187. DRUG ELUTING STENT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 188. DRUG ELUTING STENT MARKET LICENSE & PRICING